|
C60690 |
Apheresis mobilization agent plerixafor dose value |
The dose related plerixafor for mobilization agent in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60674 |
Vector integrating positive percentage value |
The percentage related to vector integrating positive cells.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60682 |
Gene ediing target Indels conversion value |
The value related to conversion.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60668 |
Drug product potency assay text |
The free-text field related to drug product potency assay.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60705 |
Apheresis plerixafor mobilization time interval value |
The time from plerixafor or mobilization agent to start of apheresis in minutes
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60713 |
Apheresis product CD34 total value |
The total value of CD34 in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60721 |
Apheresis collection next day indicator |
The indicator related to having collection for apheresis the next day.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60660 |
Genetic therapy study category type |
The type related to genetic therapy study type.
|
Supplemental |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60691 |
Apheresis mobilization agent plerixafor prior collection time value |
The value related to time prior to collection for administration of plerixafor for mobilization agent in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60675 |
Vector copy number to cell value |
The value related to vector copy number/cells
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60683 |
Gene ediing target Indels conversion percentage value |
The percentage value related to conversion.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60661 |
Genetic therapy product manufacture date |
The date related to study treatment manufacture
|
Supplemental |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60669 |
Genetic therapy subcategory treatment type |
The type of study treatment subcategory.
|
Supplemental |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60698 |
Apheresis device program used text |
The free-text field related to apheresis device manufacturer and model.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60706 |
Adverse event relate apheresis indicator |
The indicator related to adverse event from apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60714 |
Apheresis product hematocrit percentage value |
The percentage value of hematocrit in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60692 |
Apheresis mobilization other agent type |
The other type of mobilization agent used in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60676 |
Genetic therapy editing type |
The type related to type of gene editing.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60684 |
Red blood cell exchange performed most recent date |
The date related to last red blood cell exchange for treatment of sickle cell disease.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60662 |
Genetic therapy cell count |
The cell count related to biomanufacture in genetic therapy.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60670 |
Vector integrate type |
The type of vector integrating
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60699 |
Anticoagulant agent administered text |
The free-text field related to anticoagulant agent administered.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60707 |
Anticoagulant agent additional administered indicator |
The indicator related to additional anticoagulant agent being administered
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60715 |
Apheresis product white blood cell count value |
The value related to white blood cells in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60693 |
Apheresis mobilization other agent dose value |
The dose related other agent for mobilization in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
